A single universal (U) tricistronic transgene (UCAR) has successfully generated CAR‐T cells that simultaneously expressed multiple CAR molecules specific for HER2, IL13Rα2, and EphA2, which were able to capture nearly 100% of GBM tumor cells. This evidence concerns the gene EPHA2 and glioblastoma.